Design and Preparation of Novel Imidazolinone Backbone Chiral N, P Ligands and Highly Effective Performances in Enantioselective Allylations

Abstract

Based on a patented new concept of general chiral catalysis, a series of new chiral ligands integrated with both a Macmillan imidazolinone organocatalyst and a chiral N, P-ligand scaffolds have been designed and concisely prepared from commercially available chiral α-amino acids and 2-diphenylphosphino-benzaldehyde. Those chiral ligands have shown good to excellent enantioselectivities (up to 97% ee) with satisfactory yields (up to 95%) in enantioselective Pd-catalyzed allylations with 1,3-dicarbonyls and amines.

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
08 Jul 2025
Accepted
11 Aug 2025
First published
12 Aug 2025

Org. Biomol. Chem., 2025, Accepted Manuscript

Design and Preparation of Novel Imidazolinone Backbone Chiral N, P Ligands and Highly Effective Performances in Enantioselective Allylations

L. Wang, G. Cheng, S. Lu, J. Yu and Q. Zhang, Org. Biomol. Chem., 2025, Accepted Manuscript , DOI: 10.1039/D5OB01102G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements